Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases
Tuberculosis and Respiratory Diseases · 01.10.2025 · 88 (4) · 654-672
DOI: 10.4046/trd.2025.0044 ↗Kurz gefasst
Leitlinie in der Zeitschrift Tuberculosis and Respiratory Diseases, erschienen am 01.10.2025. Verfasst von Chul Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Republic of Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
Interstitial lung disease (ILD) comprises a heterogeneous group of disorders characterized by interstitial compartment proliferation, inflammatory infiltration, and potential fibrosis with abnormal collagen deposition. Diagnosis requires a multidisciplinary consensus integrating clinical, radiological, and pathological findings. Idiopathic interstitial pneumonia (IIP) includes idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia, desquamative interstitial pneumonia, acute interstitial pneumonia, and respiratory bronchiolitis-ILD, each exhibiting distinct prognostic and therapeutic implications. Some non-IPF ILDs progress despite standard treatment, classified as progressive fibrosing-ILD or progressive pulmonary fibrosis (PPF), diagnosed by worsening symptoms, physiological decline, and radiological progression. Nintedanib is conditionally recommended for refractory PPF cases. Combined pulmonary fibrosis and emphysema is characterized by upper-lobe predominant emphysema and lower-lobe fibrosis, frequently complicated by pulmonary hypertension and lung cancer. Interstitial lung abnormality, observed in both smokers and the general population, is associated with increased mortality and disease risk, warranting further research. Despite advancements, refinement in classification, diagnostic criteria, and therapeutic strategies remains crucial for improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, Gyeongju, Republic of Korea.
- Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Park, C., Yeo, Y., Woo, A., Yoo, J. W., Hong, G., Shin, J. W., & Park, S. W. (2025). Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases. Tuberculosis and Respiratory Diseases, 88(4), 654-672. https://doi.org/10.4046/trd.2025.0044
Vancouver
Park C, Yeo Y, Woo A, Yoo JW, Hong G, Shin JW, et al. Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases. Tuberculosis and Respiratory Diseases. 2025;88(4):654-672. doi:10.4046/trd.2025.0044
BibTeX
@article{Park2025,
author = {Park, Chul and Yeo, Yoomi and Woo, A La and Yoo, Jung Wan and Hong, Goohyeon and Shin, Jong Wook and Park, Sung Woo},
title = {Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases},
journal = {Tuberculosis and Respiratory Diseases},
year = {2025},
volume = {88},
number = {4},
pages = {654--672},
doi = {10.4046/trd.2025.0044}
}
EUVIMED